Cleared Traditional

K830292 - BIOELECTRICAL IMPEDANCE ANALYZER #101

K830292 is an FDA 510(k) clearance for BIOELECTRICAL IMPEDANCE ANALYZER #101, manufactured by Rjl Systems, Inc.. The device is a Class 2 Cardiovascular device with product code DSB cleared through the Traditional 510(k) pathway after a 197-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1983
Decision
197d
Days
Class 2
Risk

K830292 is an FDA 510(k) clearance for the BIOELECTRICAL IMPEDANCE ANALYZER #101. Classified as Plethysmograph, Impedance (product code DSB), Class II - Special Controls.

Submitted by Rjl Systems, Inc. (Walker, US). The FDA issued a Cleared decision on August 12, 1983 after a review of 197 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2770 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Rjl Systems, Inc. devices

FDA 510(k) Submission Details - K830292

510(k) Number K830292 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 27, 1983
Decision Date August 12, 1983
Days to Decision 197 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
72d slower than avg
Panel avg: 125d · This submission: 197d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DSB Device Classification - Class 2, Special Controls

Product Code DSB Plethysmograph, Impedance
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2770
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.